
Plenary Session
1.42 Caplacizumab for TTP with Dr. Sven Olson & Economics of Drug Pricing with Dr. Inma Hernández
1 tim 17 min•13 februari 2019
Om avsnittet
In the first half of this episode, Dr. Sven Olson of OHSU joins us to help critique the recent NEJM paper, "Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura". In the second half, we interview Dr. Inmaculada Hernández of the University of Pittsburgh on her work on the economic principles behind runaway drug prices.
Caplacizumab: doi.org/10.1056/NEJMoa1806311
Back us on Patreon! www.patreon.com/plenarysession
Fler avsnitt
Visa alla avsnitt av Plenary SessionPlenary Session med Vinay Prasad, MD MPH finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.